This review critically summarizes recent preclinical evidence on natural bioactive compounds that regulate FABP4 expression and associated adipogenic programs in models of adipogenesis and diet-induced obesity. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.